OVERVIEW ON CSO EFFORTS TO ADVOCATE FOR THE PROVISION OF SERVICES FOR PEOPLE WHO USE DRUGS IN UGANDA WAMALA TWAIBU Executive Director -UHRN

Slides:



Advertisements
Similar presentations
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Advertisements

Adapting National HIV Strategy to a Socially and Geographically Concentrated Epidemic: The Case of Papua New Guinea Dr. Moale Kariko PNG.
European Network for HIV/STI Prevention and Health Promotion among Migrant Sex Workers Access to Services and Rights for sex workers.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.
Advocacy 1. What is Advocacy? ● Organized effort to influence policy change/decision making ● Action directed at changing approach of an individual/institution/group.
Learning and Empowerment: “Key Issues in Strategies for HIV/AIDS Prevention” March 1-5, 2004, Chiang Mai Presented by Dr. Pum Sophiny, Program Officer.
Key Populations: Making Them Matter in the Global HIV Response Inextricable Links: HIV and Human Rights Kevin Osborne, LINKAGES Project Director 2 March.
© Aahung 2004 Millennium Development Goals Expanding the Agenda:
National AIDS Control Programme 1. National AIDS Control Programme (NACP) launched under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999)
Harmonizing public health and public safety in a politically conservative environment Joëlle Rabot Field Coordinator Collectif Urgence.
European Network for HIV/STI Prevention and Health Promotion among Migrant Sex Workers Access to Services and Rights for sex workers.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
“Writing our own narratives” The Global Advocacy Agenda for Young People Living with HIV.
Supporting community action on AIDS in developing countries Liza Tong Programme Manager International HIV/AIDS Alliance “Whose Value Counts”: A community.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
UNAIDS Sharing Experiences from SA Workplace Wellness Dialogues Dr Miriam Chipimo Senior Policy & Programme Adviser SA BCOHA &ILO Pre-Conference Workshop.
Community Paralegals Developing Peer Legal Support for People Who Use Drugs in Indonesia Bridging the Gaps Indonesian Drug Users Network (PKNI)
 Critical Enablers for HIV, TB & Malaria Responses UNDP & Global Fund informal session 30 th meeting of the Global Fund Board Dr Mandeep Dhaliwal United.
HIV/AIDS mainstreaming in the workplace: an experience of CSO’s Tanzania AIDS Forum HIV/AIDS Technical review meeting Blue Peal Hotel, Dar Es Salaam 30.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
“A VISION OF HOPE” EXPERIENCE OF SENEGAL IN THE FIGHT AGAINST AIDS AND REDUCING WOMEN’S VULNERABILITY Dr Khoudia Sow, CRCF, UMI 233 Dakar Sénégal.
Prevention with Positives; Using Multiple Strategies to Involve Persons Living with HIV in Prevention. TASO Uganda. Emmanuel Odeke,
Effective Drugs Policy and Harm Reduction in Tanzania
Dorcas Sithole Mental Health Department Ministry of Health & Child Welfare 1.
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Asia-Pacific High-level Meeting on HIV and AIDS The Asia-Pacific High-level Intergovernmental Meeting on the Assessment of Progress against Commitments.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
Injecting Drug Use and Drug Led HIV in Nepal Bijay Pandey Recovering Nepal.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
USERS’ INVOLVEMENT IN MENTAL HEALTH WORK. By Sylvester Katontoka
Resource Needs Model Rachel Sanders October 28 th, 2010.
Operational Plan for UNAIDS Action Framework: Addressing Women, Girls, Gender Equality and HIV February 3, 2010.
Global Partnership on Disability and Development What is the GPDD? Presentation to JICA Group Training Course HIV/AIDS Section Judith Heumann, Lead Consultant,
Project RAS/H13 “Prevention of transmission of HIV among drug users in SAARC Countries” Lubna Mohamed Zahir Hussain Chairperson of National Drug Agency.
Engaging the Judiciary/Policy makers in advocating for rights based approaches to HIV and TB Johannesburg, South Africa April 2015.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
Advisory Forum November 28th-29th 2005 HIV, AIDS and Other Sexually Transmitted and Blood Borne Infections Prof Angus Nicoll SNE - HIV & STI Co-ordinator.
4 th AMTP UA Progress Report 5 th AMTP Outcomes Framework VISION The spread of HIV is halted in the Philippines OUTCOMES Persons at-risk, vulnerable,
YONECO SRHR POLICY. SHAREFRAME CONFERENCE Salima - Malawi Mr. Samuel Bota Board Member.
International Conference on AIDS and STIs in Africa ICASA ‘ Patients Not Criminals’ - Harm Reduction Responses and Policy Reform in Kenya By Dr.
NDPHS Expert Group on HIV/AIDS and Associated Infections Draft problem tree 5 December, 2011 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen.
About ARASA  ARASA is a regional partnership of 63 grassroots, national and regional non-governmental organisations working together to promote rights-based.
Law Enforcement agencies and civil society organizations: critical partners in HIV services provision for people who use drugs Zhannat Kosmukhamedova,
Toll free call centres a preferred option for HIV/AIDS information in highly stigmatised Somalia. ICASA Nov, 2015 Abstract no: THUAD 1301 Mr.Anwar Abdirahman.
Edo Agustian Indonesian Drug Users Network Meaningful Involvement of PWID in Hep C advocacy in Indonesia.
EG HIV/AIDS & AI Internal Strategy and Action Plan Country priorities according to a survey in January-February 2014.
HIV Prevention Program for MSM in Post –Conflict Liberia
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
STRENGTHENING THE CAPACITY OF KEY POPULATIONS TO ENGAGE IN NATIONAL FUNDING PLATFORMS AND PROCESSES - TANZANIA CONTEXT ARASA PARTNERS FORUM 2015 PRESENTER;
Evidence base to promote drug policy reform in Mauritius Steeve BATOUR Board Member, PILS Co-founding member, CUT ARASA Panel Discussion April 2014 Johannesburg.
MODULE 3 Harm reduction advocacy
Key Population Community taking the Lead.
The Aviator Hotel – South Africa Uganda Harm Reduction Network (UHRN)
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Pakistan Last updated: July 2015.
Addressing Drug Use Together Through a Health Based Approach:
Community Action on Harm Reduction (CAHR) Programme
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Towards a Conducive Legal and Structural Environment
Edward Mbizo Sibanda, (MSc) Right to Care
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
Prevention of HIV infection: How effectively are countries responding to changing epidemics in the Asia Pacific Region? 30 March 2011 Slide 1 A brief introduction.
Presentation transcript:

OVERVIEW ON CSO EFFORTS TO ADVOCATE FOR THE PROVISION OF SERVICES FOR PEOPLE WHO USE DRUGS IN UGANDA WAMALA TWAIBU Executive Director -UHRN Website: Blog: 16 th April 2015

WHO IS UHRN?  Uganda Harm Reduction Network (UHRN) is a youth led drug user Network established in 2011 to respond to the drug use crisis in Uganda;  Since Inception UHRN seeks to provide a national platform for health and policy programs that promote good practices and advocate for a supportive environment for the implementation and expansion of harm reduction programs for drug users. Vision : A society where drug users are empowered to make informed decisions on the impacts of drugs use and live a life that gives them hope in Uganda. Mission : To improve the health and socio-economic well-being of drug users by offering prevention and intervention services aimed at reducing the harms associated with drug use in Uganda.

UHRN approach:  The overall approach of UHRN is benched-marked from a public health and human right based approach.  First, UHRN particularly focuses on community mobilization through outreaches, advocacy for human rights protection for drug users and drug policy reform, call for donor support for HIV-related harm reduction services, sustainable livelihood programs and advocacy for the inclusion and adoption of comprehensive harm reduction package.  Needle and Syringe Exchange programmes (NSE), Opioid Substitution Therapy (OST) and other drug dependence treatments (detox and non coercive rehab), HIV prevention, (HCT), Antiretroviral therapy, Prevention and treatment of STIs, Condom programmes for drug users and their partners, Targeted education and communication (IEC ) for PWUDs and other partners, Vaccination and diagnosis and treatment of viral hepatitis and Prevention, diagnosis and treatment of TB.  Building capacity of the Small to advocate for favourable legal and policy environment

Overview of drug use and HIV in Uganda  There is extremely limited information available on people who use drugs in Uganda, as for most-at-risk populations in general.  Yet Uganda is a key country in East Africa in terms of drug policy and harm reduction. The most common drugs used include cocaine, heroin, marijuana, alcohol and cannabis.  HIV prevalence amongst people who use drugs is unknown in Uganda, although the Country (combination of UNAIDS and UNODC data provided) estimates that HIV prevalence rate of PWID in Uganda is 11.7%, also a small-scale study of 67 sex workers who use drugs found a HIV prevalence rate of 34 per cent (IDPC Briefing Paper, HIV prevention among people who use drugs in East Africa; September 2013).  Another study conducted in Kampala (Most At Risk Population (MARPS) Network in ) highlighted HIV prevalence at 17% among injecting drug users;  However little attention is being given to them and yet they may have a major contribution to the 7.3% (Uganda AIDS Indicator Survey 2011) prevalence of the total population of Uganda.

Some of UHRN’s achievements  We have Trained 30 drug users as peer educators with support from MARPI Mulago National Referral Hospital.  Conducted 2 community meetings on human rights awareness targeting police officers, health workers and drug users.  Reached 5,918 drug users including 269 injecting drug users with HIV/AIDS, TB and HCV information.  We have referred 67 PWUD to Butabika national mental referral hospital for mental and psychotherapy treatment.  We have opened safe space(drop-in centre) for the drug users which serves as a hub where peer educators/drug users come for chats, to take their ARVs, Counseling, and health education sessions and share their personal stories and experiences, pick condoms and their referral cards to link them to treatment and other health service centres.

Achievements Cont’d...  Through our peer educators we have documented 15 drug user personal stories and experiences of human rights violations in the past six months of outreach.  5 Mediations and negations have been conducted by UHRN paralegal team for the release of our arrested members from 5 police stations.  Conducted 14 HCTs in the 5 divisions of Kampala in partnership with MARPI Mulago, and 98 out of 618 drug users whom we tested were found HIV positive and referred to MARPI Mulago for treatment. Also we Disseminated 1000 brochures with health tips on “safe & clean injecting  Conducted 8 Community sensitization dialogues on HIV and SRHR targeting drug users(IDUs and Female sex workers who use drugs),  As a result of UHRN’s Lobbying, and Networking with different stakeholders both at National and Regional level- UHRN is coordinating a Human Rights and Harm Reduction Working Group in Uganda comprising of representatives from different partner organizations that advocates for legal justice for KAPs groups in Uganda such as UGANET, HRAPF, CEHURD and Makerere University Faculty of Law-PILAC. The team is looking at providing Legal justice to cases of human rights and HIV targeting the drug users in Uganda.

Achievements Cont’d...  From our lobbying, partnerships and networking, UHRN and peer educators worked with a team of journalists from Al Jazeera to publish a documentary on “Uganda’s thriving drug scene” uganda-thrivingdrug htmlhttp:// uganda-thrivingdrug html  UHRN has worked with ARASA, KANCO and other regional partners from 8 selected countries in the drafting of the EOI and the recently submitted Regional Concept Note (RCN) on harm reduction targeting IDUs and the ARASA RCN on strengthening the legal and policy environment to reduce the impact of HIV and TB on key populations in Africa through organizing National consultative dialogues on harm reduction, presenting the two RCNs to the country’s Global fund CCM up to the point of their endorsements.  UHRN has had its concept to conducting a situation analysis to establish the drug user burden in Uganda approved by the Global fund under the cost extension funding for KAPs in Uganda...to be conducted in the Eastern border towns of Uganda (along the transit routes of drugs)

Achievement Cont’d....  UHRN also seats on the MARPS Steering Committee at Uganda AIDS Commission (UAC) which is now in the process of developing the MARPs Priority Action Plan which is ongoing.  UHRN has continued to work with SAFE under Gulu Medical Institute- School of Public Health Makerere University, Uganda Centre for Disease and Control, MARPs Network, MARPI Mulago, Butabika National Mental referral hospital, Uganda Aids Commission, HEPs, WONETHA (Women's Organization Network for Human Rights Advocacy), WGNRR (Women Global Network Reproductive Right), Civil Society Coalition On Human Rights and Constitutional Law, CHAU (Community Health Alliance Uganda), EANASO, UNDP-Ethiopia Office, CSMMUA (Coalition on Safe Mortality and Morbidity on Unsafe Abortion), ATHENA- Project to strengthen advocacy and promote the visibility of drug users human rights in Uganda, so that their human and health rights are recorganised and protected for them to access quality and comprehensive health care services and hence adopting the Harm Reduction Model in Uganda and across Eastern and Southern in the long run.

Drug users preparing their stuff for injecting and sniffing

Gaps or challenges faced by drug users/UHRN in Uganda  Lack of data for evidence-Data on PWIDs not readily available,...the available data is not provable with questionable quality and minimum efforts on generation of evidence  Thus, minimum or none PWIDs indicators in Uganda.  Drug users not a priority despite the magnitude of HIV prevalence in NSP.  Cases of overdose and homelessness which interferes with drug users HIV treatment and adherence.  Lack of treatment for drug users in cases of drug dependency Harm Reduction interventions.  Lack of data/ evidence/involvement of PWUDs in knowledge production showing good practices on PWUDs related issues (e.g. need to train People Who Use Drugs as researchers).

Gaps or challenges cont’d...  Inadequate political environment coupled with criminalization of drug use, weak policies due to limited focus.  Rampant police harassments of drug users  Stigma and discrimination of drug users in health service centres and in the community.  Limited financial support/funding for drug user tailored projects in Uganda

UHRN Recommendations:  Treat drug use as a public health issue, rather than as a criminal justice matter;  Adopt and spread harm reduction services such as needle syringe exchanges and methadone treatment services in Uganda.  Need for a national wide situation analysis to establish the drug use burden in Uganda.  Uganda need to adopt a drug policy plan, inclusive of health standards;  Create an enabling environment for drug users to develop health seeking behavior;  Need to strengthen law enforcement for more selective deterrence, focusing on high-level targets;  We Advocate for government’s investment in HIV and harm reduction programs targeting people who inject drugs in Uganda

THANK YOU !!